Evaluation of renal function testing in older Australian veterans dispensed medicines that require renal function monitoring
| Autor: | Lisa M. Kalisch Ellett, Elizabeth E. Roughead, Gizat M. Kassie, Emmae N. Ramsay, Nicole L. Pratt |
|---|---|
| Přispěvatelé: | Kalisch Ellett, Lisa M, Kassie, Gizat M, Ramsay, Emmae N, Pratt, Nicole L, Roughead, Elizabeth E |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
age-related renal decline
medicine.medical_specialty Creatinine Renal function monitoring business.industry renal function Renal function Government department medicine.disease comorbidities chemistry.chemical_compound Pharmacotherapy chemistry Dose adjustment Heart failure Diabetes mellitus Emergency medicine medicine Pharmacology (medical) Geriatrics and Gerontology business |
| Popis: | Introduction: Renal function testing should be performed prior to initiating medicines that require dose adjustment in renal impairment, with ongoing monitoring in continued use, particularly in older people. There is little evidence regarding the extent to which renal function monitoring is performed in older Australians dispensed medicines requiring renal function monitoring. Objective: The aim of this study was to determine the extent of renal function testing in older people dispensed medicines requiring renal function monitoring. Methods: A retrospective analysis of administrative claims data from the Australian Government Department of Veterans’ Affairs was conducted for people aged 65 years or older who were dispensed one or more medicines requiring renal function monitoring, from 1 June 2019 to 30 September 2019, to investigate the proportion of people with a claim for a pathology test that included creatinine levels in the 6–12 months before or after dispensing of a medicine requiring renal function monitoring. Results: There were 100,113 people who were dispensed at least one medicine requiring renal function monitoring during the study period, of whom 15% had a history of renal impairment and 16% had diabetes mellitus. Sixty-one percent had a claim for a test in the prior 6 months; this increased to 80% of participants with a claim for a test in the prior 12 months. The rate of claims for testing was lower in aged care facility residents compared with people living in the community (54% vs 62% in the previous 6 months; p < 0.001), and was higher in people with diabetes (75% vs 58%; p < 0.001), history of renal impairment (91% vs 59%; p < 0.001) or heart failure (77% vs 60%; p < 0.001) compared with those without these conditions. Conclusion: Medicines that require renal function monitoring are commonly used in older Australians, and while the majority have claims for tests that include renal function, some are missing out. Refereed/Peer-reviewed |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|